Charity investigates Ebola case

The charity save children has said ‘’no stone will be left unturned’’ in investigation into how a British nurse working at a Ebola treatment Centre contracted the disease Pauline Cafferkey, from south Lamar shire had been working with the charity in Kerry town, Sierra Leone. Ms. Cafferkey is critically ill in London hospital after her condition worsened in recent days. She was diagnosed with disease after retiring to Glasgow a week ago.
Save the children has issued a statement saying it began a ‘’serious event review ‘’ when Ms. Cafferkey was confirmed as having Ebola on 29 Dec.
The Charity is Sierra Leone director, Rob mac Gillivray, told the BBC the investigation would ‘’ensure that we do everything, leave no stone unturned, to be able to as far as possible identify the source of this infection’’ the panel is early findings will be made available ‘’as soon as possible according to the save the children.
Miss cafferkey is the second UK case of Ebola, Nurse William Pooley recovered from disease in September after also being treated at the Royal free hospital he was treated with the antivirals drug Zmapp, of which there are no stocks left anywhere in the world. But Mr. Pooley donated some blood plasma for use in treatment.
Save the children has issued a statement saying it began a ‘’serious event review ‘’ when Ms. Cafferkey was confirmed as having Ebola on 29 Dec.
The Charity is Sierra Leone director, Rob mac Gillivray, told the BBC the investigation would ‘’ensure that we do everything, leave no stone unturned, to be able to as far as possible identify the source of this infection’’ the panel is early findings will be made available ‘’as soon as possible according to the save the children.
Miss cafferkey is the second UK case of Ebola, Nurse William Pooley recovered from disease in September after also being treated at the Royal free hospital he was treated with the antivirals drug Zmapp, of which there are no stocks left anywhere in the world. But Mr. Pooley donated some blood plasma for use in treatment.